Journey Medical Corp
DERM· Nasdaq
Released Nov 12, 2024, after the close
10-Q filed Nov 12, 2024, 43 days after period end · 0001410578-24-001877
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $14.63M | $15.28M | $16.04M | $19.61M |
| Net Income | -$2.39M | $16.79M | -$10.08M | -$10.65M |
| EPS Diluted |
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR
| -$0.12 |
| $0.80 |
| -$0.57 |
| -$1.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.